A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease
Clinical trial NCT04269551 · COMPLETED
Trial details
- NCT number
- NCT04269551
- Sponsor
- Bioverativ, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-15
- Primary completion
- 2022-01-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.